INDV: Indivior PLC Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,399.33
Enterprise Value ($M) 1,349.33
Book Value ($M) -167.00
Book Value / Share -1.34
Price / Book -8.38
NCAV ($M) -832.00
NCAV / Share -6.67
Price / NCAV -1.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.03
Return on Assets (ROA) -0.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.65
Current Ratio 0.83

Balance Sheet (mrq) ($M)
Current Assets 799.00
Assets 1,464.00
Liabilities 1,631.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-15 13G Flynn James E 5.80
11-14 13G/A Scopia Capital Management Lp 4.30 -51.80
11-07 13D/A Oaktree Capital Holdings, LLC 7.50 1.56
10-17 13D/A Two Seas Capital LP 10.10 -1.73
04-09 13G SG Americas Securities, LLC 5.17
02-08 13G Morgan Stanley 7.10

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 159,849 843,257 18.96
2025-01-14 113,255 784,523 14.44
2025-01-13 99,172 736,460 13.47
2025-01-10 70,063 750,153 9.34

(click for more detail)

Similar Companies
IMUX – Immunic, Inc. IMVT – Immunovant, Inc.
INBX – Inhibrx Biosciences, Inc. INNV – InnovAge Holding Corp.
INSM – Insmed Incorporated


Financial data and stock pages provided by
Fintel.io